Acamprosate Completed Phase 4 Trials for Alcohol Abuse / Alcohol Dependence / Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00452543Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
NCT00435435Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00381043Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic